Sermorelin
GHRH (1-29) · GRF 1-29 NH2
A 29-amino acid truncated analogue of endogenous GHRH, FDA-approved for pediatric GHD and widely researched for anti-aging and body composition.
Half-Life
~10-20 minutes
MW
3357.9 Da
Amino Acids
29 AA
Evidence
High Evidence
Regulatory Status
FDA-approved (pediatric GHD), commonly compounded for adult research use. Off-label adult use common.
Research reference values only. Confirm all parameters with current literature and your clinician.
Looking for multi-compound protocols?
Browse educational protocol discussions that include Sermorelin.
Related Compounds
CJC-1295
A long-acting GHRH analogue with a Drug Affinity Complex that extends its half-life dramatically, allowing weekly dosing for sustained GH elevation.
Ipamorelin
A highly selective GH secretagogue and ghrelin receptor agonist known for clean GH release without significant cortisol or prolactin stimulation.
GHRP-2
A potent GH secretagogue with strong ghrelin receptor activity, producing significant GH pulses with some cortisol and prolactin elevation.
Tesamorelin
FDA-approved GHRH analogue specifically studied for visceral fat reduction in HIV-associated lipodystrophy, with broader anti-aging research interest.
Educational Disclaimer: All information on this page is for educational and research purposes only. This does not constitute medical advice, diagnosis, or treatment recommendation. Consult a qualified healthcare professional.